He Ren, Zewen Wu, Jingxuan Li, Nan Zhang, Coo Yee Nah, Jiexin Li, Jingyu Zhang, Jonathan F. Lovell, Liyun Zhang, Yumiao Zhang
{"title":"A biomimetic, triggered-release micelle formulation of methotrexate and celastrol controls collagen-induced arthritis in mice (4/2024)","authors":"He Ren, Zewen Wu, Jingxuan Li, Nan Zhang, Coo Yee Nah, Jiexin Li, Jingyu Zhang, Jonathan F. Lovell, Liyun Zhang, Yumiao Zhang","doi":"10.1002/bmm2.12132","DOIUrl":null,"url":null,"abstract":"<p>In this article number 10.1002/bmm2.12104, He Ren, Zewen Wu, Liyun Zhang, Yumiao Zhang and their co-authors designed an antirheumatic nanoparticle termed CeViM-micelle@B. A methotrexate-conjugated Pluronic F127 micelle was developed to encapsulate anti-inflammatory agent Celastrol (Cel) and the stabilizer Vitamin K (VK), which was further coated by B-cell membrane. The use of CeViM-micelle@B significantly increased drug accumulation at pathological synovial joints, potently inhibited immune cell activation, and effectively prevented erosion of bone and cartilage. This new nanoplatform holds potential for the next-generation targeted rheumatoid arthritis therapy.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":100191,"journal":{"name":"BMEMat","volume":"2 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmm2.12132","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMEMat","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bmm2.12132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In this article number 10.1002/bmm2.12104, He Ren, Zewen Wu, Liyun Zhang, Yumiao Zhang and their co-authors designed an antirheumatic nanoparticle termed CeViM-micelle@B. A methotrexate-conjugated Pluronic F127 micelle was developed to encapsulate anti-inflammatory agent Celastrol (Cel) and the stabilizer Vitamin K (VK), which was further coated by B-cell membrane. The use of CeViM-micelle@B significantly increased drug accumulation at pathological synovial joints, potently inhibited immune cell activation, and effectively prevented erosion of bone and cartilage. This new nanoplatform holds potential for the next-generation targeted rheumatoid arthritis therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
